P3.4 Budgetary implications (Section 4)

Page last updated: September 2016

Additional Information Requests

  • Estimate financial implications using the basis for pricing that applies to the NIP or the PBS, as relevant (Subsection 4.4)
  • Estimate extent of use and costs for primary vaccination program. Where the proposed vaccine is to replace an existing product, estimate the extent of use based on data from current estimates of vaccinated cohorts. Where the proposed vaccine is indicated for a new disease, estimate the extent of use based on standard population estimates (Subsection 4.2)
  • Estimate extent of use and costs for any catch-up cohorts (Subsection 4.2)
  • Estimate administration costs, including delivery through general practice (Subsection 4.5)

P3.4.1 Financial implications for the NIP (Subsection 4.4)

Where NIP funding is sought, estimate the costs presented in Section 4 using the price to the Australian Government that applies to vaccines funded under the NIP. Where PBS listing is sought, use the dispensed price for maximum quantity, with appropriate patient copayments removed, that applies to vaccines listed on the PBS.

P3.4.2 Extent of use and costs for primary vaccination program (Subsection 4.2)

Where NIP funding is sought, estimate wastage and usage beyond the target population. Seek the advice of the department, particularly the Immunisation Policy Section. Where an epidemiological approach is needed to modify the estimates of extent of use based on standard population estimates to estimate use in a specific target population, see also additional requests for information in response to Subsection 4.2 for possible sources of epidemiological evidence.

Specify any new or additional requirements that are likely to have an impact on the financial implications of listing the proposed vaccine.

P3.4.3 Extent of use and costs for any catch-up cohorts (Subsection 4.2)

Consistent with the additional requests for information in response to Subsection 4.2, present these estimates for a catch-up cohort as a series of marginal analyses examining the impacts of various options for the size and duration of the catch-up program.

P3.4.4 Administration costs (Subsection 4.5)

Estimate any administration costs. Present separately any cost-consequence estimates (which may vary across states and territories) to government budgets beyond the health sector (eg clinics, community centres, schools).